Cited by 600Suicide and Self-Harm StudiesNerve injury and regenerationTreatment of Major Depression

Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs

Karege, Félicien, Vaudan, Geneviève, Schwald, Michèle, Perroud, Nader, La Harpe, Romano·2005·Molecular Brain Research

Abstract

Suicide is a major public health problem but the neurobiological factors of risk are poorly understood. Recent studies have mentioned changes in the serotoninergic system and in neuronal plasticity, as well. The present investigation was undertaken to examine whether there is an abnormality in brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) proteins in suicide victims. The effect of diagnosis and drug treatments on the neurotrophins was also assessed. Thirty suicide victims (11 F/19 M) and twenty-four (10 F/14 M) drug-free non-suicide subjects, devoid of psychiatric or neurological disease, were examined. Antemortem diagnoses and toxicological analyses had been performed. The ventral prefrontal cortex (PFC), the hippocampus, and the entorhinal cortex were selected. BDNF and NT-3 levels were assayed either with the Western blot or with the ELISA method. Results indicated a significant decrease in BDNF and NT-3 levels in the hippocampus and PFC (only BDNF) but not in the entorhinal cortex, of suicide victims who were drug-free compared with non-suicide controls. The decrease was observed in all suicide victims, regardless of diagnosis. In drug-treated suicide victims, neurotrophin levels were not significantly different from non-suicide controls. This study supports a role of BDNF and NT-3 neurotrophin, in the pathophysiology of suicidal behavior. Anatomically, this role may implicate the hippocampus and the PFC but not the entorhinal cortex. The absence of change in BDNF and NT-3 levels of drug-treated suicide victims suggests that both neurotrophins are mediators of psychotropic drugs. A better understanding of the neurobiology of suicide could help detect populations at risk.

Integrity signals

Registry

Crossref · 10.1016/j.molbrainres.2004.12.020

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Postmortem PFC of human subjects with Major Depressive Disorder has reduced levels of BDNF, elevated levels of REDD1, and decreased levels of mTOR.

    “postmortem PFC of human subjects with Major Depressive Disorder (MDD), similar to stressed rodents, have reduced levels of BDNF,168–173 elevated levels of REDD1,92 and decreased levels of mTOR.92,169”
  • Expression of BDNF and BDNF receptor tyrosine kinase B genes is lower in suicide decedents, and plasma BDNF levels are low in suicide attempters.

    “Expression of BDNF and BDNF receptor tyrosine kinase B genes is lower in suicide decedents (179-181), and plasma BDNF levels are low in suicide attempters (182), perhaps reflecting a systemic genomic effect on BDNF expression.”

    From A brain-centric model of suicidal behavior (2020) · cites this paper as [179]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Karege, F., Vaudan, G., Schwald, M., Perroud, N., & La Harpe, R.
Affiliations
University Hospital of Geneva (CH)
Corresponding author
Karege, Félicien
Venue
Molecular Brain Research
Publisher
Elsevier BV
Published
2005-05
Volume
136
Issue
1-2
Pages
29-37
ISSN
0169-328X (ISSN-L)
OpenAlex
W2023501491
Cited by
600
References
37
Citations by year
2026: 7 · 2025: 17 · 2024: 13 · 2023: 20 · 2022: 22 · 2021: 27 · 2020: 27 · 2019: 31 · 2018: 33 · 2017: 26 · 2016: 36 · 2015: 44 · 2014: 41 · 2013: 32 · 2012: 50
FWCI
25.16
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Brain Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
suicide, brain-derived neurotrophic factor, neurotrophin-3, neurotrophins, ventral prefrontal cortex, hippocampus, entorhinal cortex, psychotropic drugs, antemortem diagnosis, postmortem brain, serotonergic system, neuroplasticity, neurobiology of suicide
MeSH terms
Adult, Aged, Aged, 80 and over, Analysis of Variance, Mental Disorders, Brain, Depression, Enzyme-Linked Immunosorbent Assay, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Postmortem Changes, Psychotropic Drugs, Regression Analysis, Suicide, Blotting, Western, Brain-Derived Neurotrophic Factor, Neurotrophin 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review